S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
MarketBeat Week in Review – 1/30 - 2/3
“Future Fuel” will unleash $11 trillion wave of wealth (Ad)
State of the Union: Biden sees economic glow, GOP sees gloom
Why a new Alzheimer's drug is having a slow US debut
“Future Fuel” will unleash $11 trillion wave of wealth (Ad)
Sri Lanka marks independence anniversary amid economic woes
Tesla hikes price of Model Y after US alters tax credit rule
“Future Fuel” will unleash $11 trillion wave of wealth (Ad)
Disney World unions vote down offer covering 45,000 workers
Route to Super Bowl dangerous for Mexico's avocado haulers
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
MarketBeat Week in Review – 1/30 - 2/3
“Future Fuel” will unleash $11 trillion wave of wealth (Ad)
State of the Union: Biden sees economic glow, GOP sees gloom
Why a new Alzheimer's drug is having a slow US debut
“Future Fuel” will unleash $11 trillion wave of wealth (Ad)
Sri Lanka marks independence anniversary amid economic woes
Tesla hikes price of Model Y after US alters tax credit rule
“Future Fuel” will unleash $11 trillion wave of wealth (Ad)
Disney World unions vote down offer covering 45,000 workers
Route to Super Bowl dangerous for Mexico's avocado haulers
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
MarketBeat Week in Review – 1/30 - 2/3
“Future Fuel” will unleash $11 trillion wave of wealth (Ad)
State of the Union: Biden sees economic glow, GOP sees gloom
Why a new Alzheimer's drug is having a slow US debut
“Future Fuel” will unleash $11 trillion wave of wealth (Ad)
Sri Lanka marks independence anniversary amid economic woes
Tesla hikes price of Model Y after US alters tax credit rule
“Future Fuel” will unleash $11 trillion wave of wealth (Ad)
Disney World unions vote down offer covering 45,000 workers
Route to Super Bowl dangerous for Mexico's avocado haulers
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
MarketBeat Week in Review – 1/30 - 2/3
“Future Fuel” will unleash $11 trillion wave of wealth (Ad)
State of the Union: Biden sees economic glow, GOP sees gloom
Why a new Alzheimer's drug is having a slow US debut
“Future Fuel” will unleash $11 trillion wave of wealth (Ad)
Sri Lanka marks independence anniversary amid economic woes
Tesla hikes price of Model Y after US alters tax credit rule
“Future Fuel” will unleash $11 trillion wave of wealth (Ad)
Disney World unions vote down offer covering 45,000 workers
Route to Super Bowl dangerous for Mexico's avocado haulers
OTCMKTS:GSTC

GlobeStar Therapeutics - GSTC Stock Forecast, Price & News

$0.0087
0.00 (0.00%)
(As of 02/3/2023 12:00 AM ET)
Add
Compare
Today's Range
$0.0061
$0.0093
50-Day Range
$0.01
$0.02
52-Week Range
$0.00
$0.02
Volume
2.75 million shs
Average Volume
4.27 million shs
Market Capitalization
$6.70 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
GSTC stock logo

About GlobeStar Therapeutics (OTCMKTS:GSTC) Stock

GlobeStar Therapeutics Corp. is a clinical stage biotechnology company, which engages in the manufacture and patented formulation of previously approved drugs for the treatment of Multiple Sclerosis. The company was founded by David P. Summers in 2011 and is headquartered in Richland, WA.

Receive GSTC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GlobeStar Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

GSTC Stock News Headlines

GlobeStar Therapeutics Corporation (GSTC)
GlobeStar Therapeutics Corp
Know Your Profit Potential BEFORE You Trade!
I’m Chuck Hughes, ten-time trading champion and author of the coveted e-book, “Options Trading Made Easy”, the strategy guide that will teach you to calculate your trade’s profit potential before you risk any capital. Click here for a free copy now! pixel
GlobeStar Therapeutics Corp (GSTC)
“Future Fuel” will unleash $11 trillion wave of wealth
The next major energy revolution is unfolding right now. And it could hand early investors as much as 46,700% gains…
See More Headlines
Receive GSTC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GlobeStar Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

GSTC Company Calendar

Today
2/05/2023
Fiscal Year End
9/30/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:GSTC
Fax
N/A
Employees
1
Year Founded
N/A

Profitability

Net Income
$-1,490,000.00
Pretax Margin
N/A
Return on Assets
-16,688.16%

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Market Cap
$6.70 million
Optionable
Not Optionable
Beta
1.09

Key Executives

  • James C. Katzaroff
    Chairman, President, CEO & Secretary
  • Robert Chicoski
    Chief Financial Officer & Treasurer
  • David Croom
    Executive Vice President
  • Brooke Greenwald
    Chief Marketing Officer













GSTC Stock - Frequently Asked Questions

How have GSTC shares performed in 2023?

GlobeStar Therapeutics' stock was trading at $0.0133 at the start of the year. Since then, GSTC stock has decreased by 34.6% and is now trading at $0.0087.
View the best growth stocks for 2023 here
.

Are investors shorting GlobeStar Therapeutics?

GlobeStar Therapeutics saw a increase in short interest in December. As of December 30th, there was short interest totaling 168,600 shares, an increase of 143.6% from the December 15th total of 69,200 shares. Based on an average trading volume of 18,869,100 shares, the days-to-cover ratio is presently 0.0 days.
View GlobeStar Therapeutics' Short Interest
.

What is GlobeStar Therapeutics' stock symbol?

GlobeStar Therapeutics trades on the OTCMKTS under the ticker symbol "GSTC."

How do I buy shares of GlobeStar Therapeutics?

Shares of GSTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is GlobeStar Therapeutics' stock price today?

One share of GSTC stock can currently be purchased for approximately $0.01.

How much money does GlobeStar Therapeutics make?

GlobeStar Therapeutics (OTCMKTS:GSTC) has a market capitalization of $6.70 million.

How can I contact GlobeStar Therapeutics?

GlobeStar Therapeutics' mailing address is 2500 WILCREST DRIVE 3RD FLOOR, HOUSTON TX, 77042. The official website for the company is angiosoma.com. The company can be reached via phone at (206) 451-1970 or via email at investors@angiosoma.info.

This page (OTCMKTS:GSTC) was last updated on 2/5/2023 by MarketBeat.com Staff